John M. Murabito - 23 Feb 2022 Form 4 Insider Report for Cigna Corp (CI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Feb 2022, 19:49:00 UTC
Prior SEC filing
14 Oct 2021
Next SEC filing
01 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Jill M. Stadelman, attorney-in-fact

Key filing fact

John M. Murabito filed Form 4 for Cigna Corp (CI) on 25 Feb 2022.

Key facts

  • This page summarizes John M. Murabito's Form 4 filing for Cigna Corp (CI).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 25 Feb 2022, 19:49.

Change

  • Previous filing in this sequence was filed on 14 Oct 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Award

Transaction value
$0
Shares
+2,286
Change %
+4.7%
Price
$0.000000
Shares after
50,444
Date
23 Feb 2022
Ownership
Direct
Footnotes
F1
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,746
Date
23 Feb 2022
Ownership
By 401(k)
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+10,247
Change %
Price
$0.000000
Shares after
10,247
Date
23 Feb 2022
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
10,247
Exercise price
$227.02
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These restricted shares vest in three equal annual installments beginning March 1, 2023.

Footnote F2

Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.

Footnote F3

This option vests in three equal annual installments beginning March 1, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .